Cargando…
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most common type of liver cancer, accounting for approximately 85–90% of all cases of liver cancer worldwide. The gut microbiome can serve as a potential non-invasive biomarker for early HCC detection and may also impact the effectiveness of immu...
Autores principales: | Gok Yavuz, Betul, Datar, Saumil, Chamseddine, Shadi, Mohamed, Yehia I., LaPelusa, Michael, Lee, Sunyoung S., Hu, Zishuo Ian, Koay, Eugene J., Tran Cao, Hop S., Jalal, Prasun Kumar, Daniel-MacDougall, Carrie, Hassan, Manal, Duda, Dan G., Amin, Hesham M., Kaseb, Ahmed O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571776/ https://www.ncbi.nlm.nih.gov/pubmed/37835569 http://dx.doi.org/10.3390/cancers15194875 |
Ejemplares similares
-
Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma—A Narrative Review
por: Chamseddine, Shadi, et al.
Publicado: (2023) -
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma
por: Chamseddine, Shadi, et al.
Publicado: (2023) -
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2021) -
Origin and role of hepatic myofibroblasts in hepatocellular carcinoma
por: Yavuz, Betul Gok, et al.
Publicado: (2020) -
Association of dietary fat intake and hepatocellular carcinoma among US adults
por: Moussa, Iman, et al.
Publicado: (2021)